Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Adult female acne is complex and requires a combination of treatments for effective management.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Adult female acne requires personalized treatment and maintenance to prevent relapse.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The effects of estrogen on human hair growth are unclear and need more research.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Eating dairy and high glycemic foods may increase the risk of acne.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Hormonal imbalances are a key cause of missed menstrual periods in women.

A Western diet may increase acne risk, while a Mediterranean diet and certain supplements can help reduce it.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.